| Literature DB >> 35864868 |
Radosław Michalski1, Renata Smulik-Izydorczyk1, Jakub Pięta1, Monika Rola1, Angelika Artelska1, Karolina Pierzchała1, Jacek Zielonka2, Balaraman Kalyanaraman2, Adam Bartłomiej Sikora1.
Abstract
Azanone (HNO, also known as nitroxyl) is the protonated form of the product of one-electron reduction of nitric oxide (•NO), and an elusive electrophilic reactive nitrogen species of increasing pharmacological significance. Over the past 20 years, the interest in the biological chemistry of HNO has increased significantly due to the numerous beneficial pharmacological effects of its donors. Increased availability of various HNO donors was accompanied by great progress in the understanding of HNO chemistry and chemical biology. This review is focused on the chemistry of HNO, with emphasis on reaction kinetics and mechanisms in aqueous solutions.Entities:
Keywords: HNO; azanone; chemical kinetics; nitroxyl; reaction mechanism
Year: 2022 PMID: 35864868 PMCID: PMC9294461 DOI: 10.3389/fchem.2022.930657
Source DB: PubMed Journal: Front Chem ISSN: 2296-2646 Impact factor: 5.545
Second-order rate constants for reactions of HNO with its scavengers.
|
|
| |
|---|---|---|
| Inorganic scavengers | ||
| HNO | (8 ± 3) × 106 |
|
| •NO | (5.8 ± 0.2) × 106 |
|
| OH− | (4.9 ± 0.5) × 104 |
|
| 3NO− | 6.6 × 109 |
|
| O2 | 8 × 103 |
|
| (1.8 ± 0.3) × 104 |
| |
| 3 × 103 |
| |
| NO2 − | 1 × 103 |
|
| (5.0 ± 0.9) × 103 |
| |
| NH2OH | (4.0 ± 0.3) × 103 |
|
| (2.1 ± 0.4) × 104 |
| |
| HS− | (1.2 ± 0.3) × 106 |
|
| HSO3 − | (1.2 ± 0.2) × 106 |
|
| S2O3 2− | (2.2 ± 0.7) × 104 |
|
| 2.1 × 104 |
| |
| Thiols and selenols | ||
| GSH | 2 × 106 |
|
| 7.6 × 106 |
| |
| (3.1 ± 0.6) × 106 |
| |
| NAC | 5 × 105 |
|
| (1.4 ± 0.3) × 106 |
| |
| Cys | (4.5 ± 0.9) × 106 |
|
| Captopril | (6 ± 1) × 105 |
|
| HSA | (1.4 ± 0.4) × 106 |
|
| BSA | (1.4 ± 0.3) × 106 |
|
| Aryl sulfinates | ||
| Benzenesulfinate anions | (4.4 ± 0.9) × 104 |
|
| 2-Bromo substituted benzenesulfinate anions (2-BrPhSO2 −) | (5.0 ± 1.2) × 104 |
|
| 2-Chloro substituted benzenesulfinate anions (2-ClPhSO2 −) | (3.0 ± 0.7) × 104 |
|
| 2-Trifluoromethyl-benzenesulfinates (2-CF3PhSO2 −) | (1.1 ± 0.2) × 104 |
|
|
| ||
| Nitrosobenzene | >1.5 × 105 |
|
| 2-Nitroso-1-naphthol | (1.0 ± 0.2) × 106 |
|
| S-nitrosoglutathione | (2.4 ± 0.7) × 104 |
|
| Phosphines | ||
| Tris (2,4-dimethyl-5- sulfophenyl)phosphine trisodium salt | 9 × 105 |
|
| Triphenylphosphine-3,3′,3″-trisulfonate | (3.0 ± 0.5) × 106 |
|
| Tris-carboxyethylphosphine | (1.2 ± 0.3) × 107 |
|
| (8.4 ± 1.8) × 106 |
| |
| C-nucleophiles | ||
| 3,4-dimethyl-1-phenyl-pyrazolin-5-one | ∼8 × 105 |
|
| 1,3-Cyclopentanedione (C5H6O2) | (2.8 ± 0.6) × 102 |
|
| 1,3-Cyclohexanedione (C6H8O2) | (2.2 ± 0.4) × 103 |
|
| 1,3-Cycloheptanedione (C7H10O2) | (6.8 ± 1.5) × 103 |
|
| 2-Methyl-1,3-cyclopentanedione (CH3C5H6O2) | (3.2 ± 0.9) × 103 |
|
| 2-Methyl-1,3-cyclohexanedione (CH3C6H8O2) | (1.1 ± 0.2) × 104 |
|
| 2,4-Piperidinedione | (2.0 ± 0.4) × 104 |
|
| 1-(4-Methoxybenzyl)-2,4-piperidinedione | (1.4 ± 0.3) × 104 |
|
| 2-Thiobarbituric acid | (8.2 ± 1.9) × 102 |
|
| Meldrum’s acid | (8.7 ± 1.8) × 102 |
|
| Cyt | 2 × 104 |
|
| 4 × 104 |
| |
| Cu,Zn-SOD | 8 × 104 |
|
| 0.7–1 × 106 |
| |
| TEMPO | (1.4 ± 0.2) × 105 |
|
| 6.3 × 104 |
| |
| TEMPOL | (1.4 ± 0.2) × 105 |
|
| 8 × 104 |
| |
| 3-Carbamoyl-PROXYL | (4.3 ± 0.4) × 104 |
|
| 4-Acetamido-TEMPO | (8 ± 2) × 104 |
|
| TEMPO-9-AC | 8 × 104 |
|
| (9 ± 2) × 104 |
| |
| PTIO | (1.4 ± 0.2) × 105 |
|
| c-PTIO | (1.4 ± 0.2) × 105 |
|
| (2.2 ± 0.5) × 104 |
| |
| (1.2 ± 0.4) × 105 | calculated based on the | |
| (6.8 ± 1.3) × 103 |
| |
| (3.6 ± 1.1) × 104 | calculated based on the | |
| Fe(CN)6 3− | (9.6 ± 7.5) × 102 |
|
| (5.0 ± 4.5) × 103 | calculated based on the | |
| NADH, NADPH, ascorbate and other reductants | ||
| NADH | (1.1 ± 0.2) × 104 |
|
| NADPH | (1.3 ± 0.4) × 104 |
|
| Ascorbate | 1.1 × 105 |
|
| Trolox | 2 × 104 |
|
| Selenomethionine | 9 × 103 |
|
Second-order rate constants for reactions of porphyrins with HNO and HNO donors.
| Compound | Reactant | Rate constant (M−1s−1) | References |
|---|---|---|---|
| Mb(FeII)O2 | HNO | 1 × 107 |
|
| Mb(FeII) | HNO | >1.4 × 104 |
|
| Mb(FeII) (origin: horse) | HNO | 2.2 × 105 |
|
| Mb(FeII) (origin: equine) | HNO | 3.7 × 105 |
|
| Hb(FeII) (origin: human) | HNO | ∼2.0 × 105 |
|
| Leghemoglobin lgHb(FeII) (origin: phytoglobin from root nodules of leguminous plants) | HNO | 1.2 × 105 |
|
| Hemoglobin I (cHb(FeII) (origin: invertebrate clam | HNO | 9.0 × 105 |
|
| metMb (Mb(FeIII)) | HNO | 8.0 × 105 |
|
| HNO | 2.7 × 105 (pH 7.0) |
| |
| 1.1 × 105 (pH 9.4) | |||
| Catalase(FeIII) | HNO | 3 × 105 |
|
| HRP(FeIII) | HNO | 2 × 106 |
|
| cyt c(FeIII) | HNO | 4 × 104 |
|
| HNO | 2 × 104 |
| |
| Fe(III) microperoxidase 11 [FeIIIMP11]3- | HNO | (6.4 ± 0.5) × 104 (pH 7) |
|
| HNO | (3.1 ± 0.4) × 104 (pH 10) |
| |
| [FeIIITSPP]3− (Fe(III) | HNO | 1 × 106 (pH 7) |
|
| AS | 0.5 (pH 7) |
| |
| [MnIIITSPP]3- | HNO | ∼4 × 104 (pH 7) |
|
| HNO | ∼9 × 104 (pH 10) |
| |
| [FeIIITEPyP]5+ | AS | (5.4 ± 0.2) × 103 (pH 7) |
|
| (Fe(III) Tetrakis N-ethylpyridinium-2-yl porphyne) | |||
| [FeIIITEPyP]5+ | TSHA | (1.1 ± 0.3) × 104 (pH 10) |
|
| Toluene sulfohydroxamic acid | |||
| [MnIIITEPyP]5+ | AS | (1.2 ± 0.1) × 104 (pH 7) |
|
| AS | (3.6 ± 0.4) × 104 (pH 10) |
| |
| TSHA | (8.1 ± 0.3) × 101 (pH 7) |
| |
| TSHA | (1.00 ± 0.05) × 104 (pH 10) |
| |
| [MnIIIBr8TCPP]3− (Mn(III) β-octa- bromo- | AS | (3.3 ± 0.3) × 103 (pH 7) |
|
| TSHA | (4.4 ± 0.5) × 103 (pH 10) |
| |
| [MnIIIBr8TSPP]3− (Mn(III) β-octa- bromo- | AS | (3.7 ± 0.3) × 103 (pH 7) |
|
| TSHA | (3.9 ± 0.2) × 103 (pH 10) |
| |
| [MnIIIT (TriMA)P]5+ | HNO | (1.1 ± 0.3) × 105 (pH 7) |
|
| (Mn(III) | |||
| AS | (5.4 ± 0.2) × 10–2 (pH 7) |
| |
| [MnIIITCPP]3− (Mn(III) | HNO | (2.9 ± 0.5) × 105 (pH 7) |
|
| HNO | (1.6 ± 0.4) × 105 (pH 7) |
| |
| [MnIIIProtoP]− (Mn(III) protoporphyrin-IX) | HNO | (4.28 ± 0.04) × 105 (pH 7) |
|
| HNO | (1.86 ± 0.07) × 105 (pH 10) |
| |
| [MnIIIHematoP]− (Mn(III) hematoporphyrin IX) | HNO | (1.6 ± 0.3) × 105 (pH 7) |
|
| HNO | (2.0 ± 0.5) × 105 (pH 10) |
| |
| [MnIIIT-2-PyP]+ | HNO | (2.1 ± 0.4) × 105 (pH 7) |
|
| (Mn(III) | |||
| Mb(MnIII) | HNO | 3.4 × 105 (pH 7.4) |
|
| (Mn(III) protoporphyrinate IX in apomyoglobin) | |||
SCHEME 1Reaction model used to determine the rate constants of the reactions between HNO and its scavengers with the use of boronate probes, the competition kinetic approach and HNO reaction with O2 as a reference reaction.
SCHEME 2Reactivity of azanone towards selected inorganic scavengers.
SCHEME 3Reactivity of azanone towards thiols and selenols. Reaction of HNO with thiols (A) and selenols (B); (C) chemical transformations of sulfinamides, (D) reaction of HNO with C-terminal cysteines.
SCHEME 4Reactivity of azanone towards phosphines (A), (B) The Staudinger ligation of HNO-derived aza-ylide. (C) The mechanism of HNO detection with the use of phosphine-based fluorogenic probes.
FIGURE 1Reactivity of HNO towards cyclic C-nucleophiles.
SCHEME 5The reactivity of HNO towards organic nucleophiles.
SCHEME 6Redox reactions in HNO/nitronyl nitroxide system.